Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONCO Onconetix Inc.

交易中 03-24 12:18:18 EDT

0.6699

+0.0682

+11.33%

最高0.6699	最低0.5770	成交量11.08万
今开0.6100	昨收0.6017	日振幅15.44%
总市值240.11万	流通市值84.15万	总股本358.42万
成交额6.74万	换手率8.82%	流通股本125.61万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":0.6699,"timestamp":1774369097170,"preClose":0.6017,"halted":0,"volume":110803,"delay":0,"changeRate":0.11334552102376606,"floatShares":1256100,"shares":3584200,"eps":-16.562977,"marketStatus":"交易中","change":0.0682,"latestTime":"03-24 12:18:18 EDT","open":0.61,"high":0.6699,"low":0.577,"amount":67402.00340258,"amplitude":0.154396,"askPrice":0.6974,"askSize":100,"bidPrice":0.6303,"bidSize":129,"shortable":0,"etf":0,"ttmEps":-16.562977,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":0.6017,"preHourTrading":{"tag":"盘前","latestPrice":0.6,"preClose":0.6017,"latestTime":"09:27 EDT","volume":3733,"amount":2240.34968425,"timestamp":1774358842112,"change":-0.0017,"changeRate":-0.002825,"amplitude":0.115506},"postHourTrading":{"tag":"盘后","latestPrice":0.6024,"preClose":0.6017,"latestTime":"19:56 EDT","volume":5614,"amount":3381.9273,"timestamp":1774310208459,"change":0.0007,"changeRate":0.001163,"amplitude":0.005817},"volumeRatio":2.341414},"requestUrl":"/m/hq/s/ONCO","defaultTab":"news","newsList":[{"id":"2617370567","title":"Onconetix, Inc.盘中异动 股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617370567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617370567?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:57","pubTimestamp":1772636266,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日22时57分，Onconetix, Inc.股票出现波动，股价急速下跌5.53%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Can Fite Biopharma Ltd、Moolec Science Sa C/Wts 30/01/2028、Scisparc Ltd.涨幅较大，Can Fite Biopharma Ltd、Klotho Neurosciences, Inc.、Onconetix, Inc.较为活跃，换手率分别为2160.20%、50.65%、34.32%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Can Fite Biopharma Ltd、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为51.24%、41.60%、39.80%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030422574697a80e54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030422574697a80e54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2614022286","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614022286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614022286?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:08","pubTimestamp":1772118485,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日23时08分，Onconetix, Inc.股票出现波动，股价大幅下跌5.06%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为1.92%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226230806a722f4c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226230806a722f4c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1122725427","title":"Onconetix Inc：Realbotix母公司预计持有合并后公司75%至90%的完全稀释普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1122725427","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122725427?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:01","pubTimestamp":1770901302,"startTime":"0","endTime":"0","summary":"Onconetix Inc.宣布，在完成合并后，Realbotix的母公司预计将持有合并后公司完全稀释普通股总数的75%至90%。这一股权结构安排显示了Realbotix母公司在新实体中的主导地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1133878432","title":"Onconetix Inc. 将以全股票交易方式收购 Realbotix 全部已发行在外股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1133878432","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133878432?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:01","pubTimestamp":1770901295,"startTime":"0","endTime":"0","summary":"Onconetix Inc. 宣布，已达成协议将收购 Realbotix 的 100% 已发行在外股权权益，本次交易将完全通过股票方式进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2610651856","title":"Onconetix, Inc.盘中异动 早盘快速拉升5.98%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610651856?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:32","pubTimestamp":1770647558,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时32分，Onconetix, Inc.股票出现波动，股价大幅拉升5.98%。截至发稿，该股报1.24美元/股，成交量614股，换手率0.04%，振幅0.81%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223238a6e68e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209223238a6e68e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2608815965","title":"Onconetix, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608815965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608815965?lang=zh_cn&edition=full","pubTime":"2026-02-02 23:46","pubTimestamp":1770047191,"startTime":"0","endTime":"0","summary":"北京时间2026年02月02日23时46分，Onconetix, Inc.股票出现异动，股价大幅跳水5.28%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202234631a473eb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202234631a473eb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2603057646","title":"Onconetix, Inc.盘中异动 下午盘大幅上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603057646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603057646?lang=zh_cn&edition=full","pubTime":"2026-01-15 02:30","pubTimestamp":1768415408,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日02时30分，Onconetix, Inc.股票出现波动，股价大幅上涨5.41%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Bioatla, Inc.、Scinai Immunotherapeutics Ltd涨幅较大，Briacell Therapeutics Corp.、Clearmind Medicine Inc.、Nrx Pharmaceuticals, Inc.较为活跃，换手率分别为248.64%、80.08%、70.18%，振幅较大的相关个股有Alpha Tau Medical Ltd C/Wts 、Briacell Therapeutics Corp C/Wts 、60 Degrees Pharmaceuticals, Inc.，振幅分别为56.54%、46.51%、39.81%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011502300897a1d5c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011502300897a1d5c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1175357476","title":"Onconetix Inc.: 提交29.8百万普通股回售的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1175357476","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175357476?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:09","pubTimestamp":1766401780,"startTime":"0","endTime":"0","summary":"Onconetix Inc.: 提交29.8百万普通股回售的招股说明书 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1172459660","title":"Onconetix Inc. - 提交22.1百万普通股转售的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1172459660","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172459660?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:36","pubTimestamp":1763570197,"startTime":"0","endTime":"0","summary":"11月5日 - Onconetix Inc. ::*ONCONETIX INC - 提交22.1百万普通股转售的招股说明书，卖方股东 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2580417790","title":"Onconetix, Inc.盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580417790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580417790?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:50","pubTimestamp":1761918624,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日21时50分，Onconetix, Inc.股票出现异动，股价大幅下挫5.80%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Ardelyx, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Travere Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为915.51%、220.19%、134.78%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Intensity Therapeutics, Inc.，振幅分别为24.63%、21.96%、20.64%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103121502494e796a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103121502494e796a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1147603757","title":"Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1147603757","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147603757?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:09","pubTimestamp":1760609347,"startTime":"0","endTime":"0","summary":"Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2572581647","title":"Onconetix, Inc.盘中异动 快速跳水5.61%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572581647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572581647?lang=zh_cn&edition=full","pubTime":"2025-09-30 23:56","pubTimestamp":1759247769,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日23时56分，Onconetix, Inc.股票出现波动，股价快速跳水5.61%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Scisparc Ltd.、Zura Bio Limited涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2059.74%、316.11%、281.99%，振幅较大的相关个股有Zura Bio Limited、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为50.84%、44.81%、35.39%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930235609a44ee002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930235609a44ee002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1140205978","title":"Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资，终止与Ocuvex Inc.的并购协议并与Veru Inc.达成880万美元债务和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1140205978","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140205978?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:33","pubTimestamp":1758889989,"startTime":"0","endTime":"0","summary":"Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资，同时终止与Ocuvex Inc.的并购协议，并与Veru Inc.达成880万美元债务和解。\n此次融资将为公司提供重要的资金支持，而终止与Ocuvex Inc.的合并协议以及与Veru Inc.达成的债务和解协议，将有助于公司重新调整战略方向，专注于核心业务发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1160349549","title":"Onconetix Inc与Ocuvex决定各自独立发展最符合利益相关者利益","url":"https://stock-news.laohu8.com/highlight/detail?id=1160349549","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160349549?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:17","pubTimestamp":1758889038,"startTime":"0","endTime":"0","summary":"Onconetix Inc与Ocuvex经过评估后认为，双方各自独立发展的路径最符合利益相关者的最佳利益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2518327463","title":"Onconetix, Inc.盘中异动 急速下跌10.39%报0.206美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518327463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518327463?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613561,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Onconetix, Inc.股票出现异动，股价快速下挫10.39%。截至发稿，该股报0.206美元/股，成交量24.7271万股，换手率1.70%，振幅8.13%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213241abf2fc8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213241abf2fc8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2516634706","title":"Onconetix, Inc.盘中异动 早盘股价大涨8.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634706?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012392,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Onconetix, Inc.股票出现波动，股价大幅拉升8.04%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.50%、28.40%、23.97%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Bioxcel Therapeutics, Inc.，振幅分别为21.22%、19.25%、10.83%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223313abe633de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223313abe633de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2514032000","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.57%报0.290美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514032000?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Onconetix, Inc.股票出现异动，股价快速下挫5.57%。截至发稿，该股报0.290美元/股，成交量4.7292万股，换手率0.33%，振幅1.30%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822313896341932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822313896341932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","VRPX","BK4139","BK4007"],"gpt_icon":0},{"id":"2512314483","title":"Onconetix, Inc.盘中异动 早盘股价大跌5.60%报0.472美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512314483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512314483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:38","pubTimestamp":1739975921,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时38分，Onconetix, Inc.股票出现波动，股价急速下挫5.60%。截至发稿，该股报0.472美元/股，成交量6.3897万股，换手率0.44%，振幅2.60%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223841988b32da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223841988b32da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2510863052","title":"Onconetix, Inc.盘中异动 急速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863052?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:39","pubTimestamp":1739198358,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时39分，Onconetix, Inc.股票出现波动，股价急速跳水5.26%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1867.40%、1005.17%、682.93%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Invivyd, Inc.，振幅分别为42.01%、34.46%、29.90%。Onconetix, Inc.公司简介：Onconetix Inc 是一家商业阶段的生物技术公司，专注于男性健康和肿瘤学创新解决方案的研究、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223918abc9a72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223918abc9a72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","ONCO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconetix.com","stockEarnings":[{"period":"1week","weight":0.1668},{"period":"1month","weight":-0.2062},{"period":"3month","weight":-0.6192},{"period":"6month","weight":-0.8102},{"period":"1year","weight":-0.9447},{"period":"ytd","weight":-0.6143}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Onconetix, Inc.于2018年10月22日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.03565},{"month":2,"riseRate":0,"avgChangeRate":-0.307055},{"month":3,"riseRate":0.2,"avgChangeRate":-0.166218},{"month":4,"riseRate":0,"avgChangeRate":-0.309723},{"month":5,"riseRate":0.75,"avgChangeRate":0.202403},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145881},{"month":7,"riseRate":0.25,"avgChangeRate":0.061534},{"month":8,"riseRate":0,"avgChangeRate":-0.163365},{"month":9,"riseRate":0.25,"avgChangeRate":-0.19953},{"month":10,"riseRate":0.25,"avgChangeRate":-0.216685},{"month":11,"riseRate":0.25,"avgChangeRate":-0.325466},{"month":12,"riseRate":0,"avgChangeRate":-0.20858}],"exchange":"NASDAQ","name":"Onconetix Inc.","nameEN":"Onconetix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Onconetix Inc.,ONCO,Onconetix Inc.股票,Onconetix Inc.股票老虎,Onconetix Inc.股票老虎国际,Onconetix Inc.行情,Onconetix Inc.股票行情,Onconetix Inc.股价,Onconetix Inc.股市,Onconetix Inc.股票价格,Onconetix Inc.股票交易,Onconetix Inc.股票购买,Onconetix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}